Clarus Therapeutics
CompanyUnited StatesFounded 2003
Clarus Therapeutics develops one asset, approved (testosterone in hormone deficiency). Mostly small molecule acting on lipid and ceramide metabolism and AR; based in the United States, founded in 2003.
- 1
- Asset
- Furthest
- Approved
- 11
- Trials
- 1
- Signal
Pipeline
1Oral testosterone replacement therapy acting as an androgen receptor agonist.
Approved, Small molecule, Lipid and ceramide metabolism, AR, hormone deficiency, hypoactive sexual desire disorder
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Evidence behind the mechanisms3
- Trials13
- Signals1
- Similar companies6
Updated 8 Oct 2026 · 85 sources